Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Eq - The Untold Story

Equillium Inc. (NASDAQ:EQ) stock traded higher Monday after the company announced up to $50 million in financing through a securities purchase agreement with investors to advance EQ504.

Benzinga

3 Small-Cap Healthcare Stocks Wall Street Loves

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….

StockNews.com

3 Biotech Stocks Under $20 Worth Watching in June

The biotech industry’s long-term expansion is fueled by increasing medical needs globally, favorable government support, and technological advances. Given the industry’s rosy outlook, quality biotech stocks Equillium (EQ), SIGA Technologies (SIGA), and Shionogi & Co. (SGIOY) trading under $20 could be worth watching in June. Keep reading….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Malaysia welcomes Chinese tourists back in droves after pandemic slump

Kuala Lumpur targets record 5 million Chinese visitors in 2024 as it hopes to accelerate post-pandemic recovery.

Al Jazeera

4 A-Rated Biotech Stocks Sparking Investor Interest

The biotech industry is rapidly evolving thanks to the surging biopharma M&A activity and incorporation of new technological trends like AI and gene editing. Given this backdrop, quality biotech stocks Gilead Sciences (GILD), Equillium (EQ), Incyte Corporation (INCY), and Jazz Pharmaceuticals plc (JAZZ), rated A (Strong Buy) overall in our…

StockNews.com

Eyeing Growth? Check Out These 3 Biotech Stock Buys

Robust government support coupled with rapid tech advancements is bolstering the biotech sector. Hence, investors eyeing growth might buy fundamentally solid biotech stocks Theratechnologies (THTX), Equillium (EQ), and BioMarin Pharmaceutical (BMRN), with massive growth potential. Read on.

StockNews.com

3 Biotech Stocks Making Major Moves on Wall Street

The biotechnology industry is experiencing significant growth, fueled by government initiatives, rising investments and tech advancements. Therefore, it could be wise to consider fundamentally strong biotech stocks Shionogi & Co (SGIOY), Equillium (EQ), and BioMarin Pharmaceutical (BMRN), which are making major moves on wall street. Read more.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Smart Biotech Picks for Your 2024 Portfolio

The biotech industry is expanding as a result of consistent technological advancements and rising investments. So, it could be wise to buy quality biotech stocks Equillium (EQ), Shionogi (SGIOY), and Theratechnologies (THTX) in 2024. Read on.

StockNews.com

Nigeria 1-1 Equatorial Guinea: Africa Cup of Nations – as it happened

Equatorial Guinea took the lead, and though the more-fancied Nigeria equalised soon after, Victor Osimhen missed their only clear-cut chance to win the match

The Guardian - UK

3 Biotech Stocks to Keep an Eye on in 2024

The biotechnology industry is witnessing remarkable expansion, propelled by notable advances in drug development, an increase in merger and acquisition activities, proliferation of technological innovations, and strong backing from the government. Given this backdrop, quality biotech stocks Acorda Therapeutics (ACOR), Organogenesis Holdings (ORGO), and Equillium (EQ) could be kept an…

StockNews.com

2024 Buys: Top Biotech Stock Trio to Consider

The biotechnology industry is experiencing significant growth, fueled by rising technological innovations and government support. Therefore, it could be wise to consider fundamentally strong biotech stocks Genfit (GNFT), Equillium (EQ), and Innoviva (INVA) for 2024. Read more.

StockNews.com

Top 3 Biotech Stocks for Weekly End-of-Year Profits

In the ever-evolving realm of biotechnology, technological advancements and breakthroughs are propelling significant growth. Hence, fundamentally strong biotech stocks Equillium (EQ), United Therapeutics (UTHR), and Vertex Pharmaceuticals (VRTX) might be solid investments for weekly year-end gains. Read more….

StockNews.com

3 Revolutionary Biotech Stocks Worth Investing In

The biotech industry's upward momentum is underpinned by the growth of personalized medicine, orphan drugs, innovative biotech tools, and robust government backing. Hence, revolutionary biotech stocks Equillium (EQ), Protalix BioTherapeutics (PLX), and Incyte Corporation (INCY) could make ideal additions to your portfolio at present. Read more….

StockNews.com

3 Brilliant Biotech Stocks to Buy for Your Portfolio

The biotech industry is flourishing on the backs of positive clinical trials and new developments. Thus, it could be beneficial to add fundamentally robust biotech stocks BioMarin Pharmaceutical (BMRN), Equillium (EQ), and Organogenesis Holdings (ORGO) to your portfolios. Read more….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Top 3 Biotech Stocks to Watch and Buy for Healthy Profits

With innovative approaches and cutting-edge technologies, biotech has ushered in a new era of possibilities in the medical field. Hence, investing in three fundamentally sound biotech stocks, Equillium, Inc. (EQ), Theratechnologies (THTX), and Exelixis (EXEL), could yield healthy profits. Learn more….

Motor1

Mercedes GLA / EQA Crossover Replacement Spied For The First Time

The electric GLA was spotted with provisional lights.

Birmingham Post

HSBC to relocate to new South West headquarters in Bristol

Bank says hundreds of its staff are set to move to the EQ office building in the city centre

Birmingham Post

Bristol office market ‘holding firm’ amid economic headwinds

Real estate firm Avison Young says has published its latest report across the ‘Big Nine’ UK office markets

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock

Olumiant (baricitinib), a Janus kinase (JAK) inhibitor, was developed by Incyte Corp (NASDAQ:INCY) and launched in collaboration with Eli Lilly And Co (NYSE:LLY), received FDA approval for hair loss disorder known as alopecia areata (AA). Olumiant was first approved for the treatment of rheumatoid arthritis (RA) in 2018. The above nod is expected to…

Insider UK

Accountancy firm appoints three new managing partners

Changes made as current leader moves to a part-time consulting role

Benzinga

Equillium's Itolizumab Shows Durable Clinical Response In GvHD Patients

Equillium Inc (NASDAQ: EQ) announced two oral presentations on itolizumab at the Annual Meeting of the European Society for Blood and Marrow Transplantation.

Benzinga

Equillium Adds Three Drugs To Its Pipeline Via Bioniz Acquisition

Equillium Inc (NASDAQ: EQ), with only one asset in its pipeline, is expanding its drug development efforts via the

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals Incorporated

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.